Furthermore, treatment of GBM xenografts with chimeric U1/ribozymes targeting HGF and c-MET mRNA sensitized tumors to gamma radiation, and greatly improved tumor regression and cure rate (115). The gene discussed is MET; the disease is glioblastoma.